Article

IOL range expands

An IOL (Softec HD, Lenstec) for treating cataracts now is available in an expanded range of prescriptions, covering 15.0 to 25.0 D. Since its approval by the FDA in April 2010, it had been available in mid-range powers between 18.0 and 25.0 D.

St. Petersburg, FL-An IOL (Softec HD, Lenstec) for treating cataracts now is available in an expanded range of prescriptions, covering 15 to 25 D. Since its approval by the FDA in April 2010, it had been available in mid-range powers between 18 and 25 D.

The bi-aspheric IOL has a stable uniplanar design and is manufactured to a tolerance of ±0.11 D, making it the most predictable IOL on the U.S. market, according to the company, which notes that the industry standard 0.40-D tolerance is set in accordance with less-stringent ISO guidelines.

The company’s proprietary manufacturing process is designed to reduce variability and produce the IOL in non-overlapping 0.25-D increments throughout its full 15- to 25-D range. In contrast, most IOLs are manufactured in 0.50-D increments that may overlap, according to the company.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.